Rapid reversal of coagulopathy in patients on platelet aggregation inhibitors immediately prior to renal transplantation with recombinant factor VIIa? [3]

Transplant International

Volumn 19, Issue 6, 2006, Pages 519-520

  Loertzer, Hagen ^a   Soukup, Jens ^a   Fornara, Paolo ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DESMOPRESSIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BLEEDING TIME; BLOOD CLOTTING DISORDER; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LETTER; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION INHIBITION; TREATMENT INDICATION;

BLEEDING TIME; BLOOD COAGULATION; BLOOD PLATELETS; DEAMINO ARGININE VASOPRESSIN; FACTOR VIIA; HEMOSTASIS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PLATELET AGGREGATION; RECOMBINANT PROTEINS; THROMBIN;

EID: 33646689365     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2006.00302.x     Document Type: Letter

References (16)

1. Levi M Bijsterveld NR Keller TT Recombinant factor VIIa as an antidote for anticoagulant treatment Semin Hematol 2004 41 65
2. Galan AM Tonda R Pino M Reverter JC Ordinas A Escolar G Increased local procoagulant action: a mechanism contributing to the favourable. hemostatic effect of recombinant FVIIa in PLT disorders Transfusion. 2003 43 885
3. Guesde R Barrou B Leblanc I et al. Administration of desmopressin in brain-dead donors and renal function in kidney recipients Lancet 1998 352 1178
4. Steiner RW Coggins C Carvalho AC Bleeding time in uremia: a useful test to assess clinical bleeding Am J Hematol 1979 7 107
5. Mattix H Singh AK Is the bleeding time predictive of bleeding prior to a percutaneous renal biopsy Curr Opin Nephrol Hypertens 1999 8 715
6. Lind SE The bleeding time does not predict surgical bleeding Blood. 1991 77 2547
7. Ruzicka H Björkman S Lethagen S Sterner G Pharmacokinetics and antidiuretic effect of high-dose desmopressin in patients with chronic renal failure Pharmacol Toxicol 2003 92 137
8. Mayer SA Brun NC Begtrup K et al. Recombinant activated factor VII for acute intracerebral hemorrhage N Engl J Med 2005 352 777
9. Gielen-Wijffels SE van der Mook WN van Geest S Ramsay G Successful treatment of severe bleeding with recombinant factor VIIa after kidney transplantation Intensive Care Med 2004 30 1232
10. Dunkley SM Mackie F Recombinant factor VIIa used to control massive haemorrhage during renal transplantation surgery; vascular graft remained patent Hematology 2003 8 263
11. Sander M von Heymann C Kox WJ et al. Recombinant factor VIIa for excessive bleeding after thrombectomy prior to kidney transplantation Transplantation. 2004 77 1912
12. Flurdal PA Sahlin S Use of desmopressin to prevent bleeding complications in patient treated with aspirin Br J Surg 1993 80 723
13. Wilbourn B Harrison P Mackie IJ Liesner R Machin SJ Activation of platelets in whole blood by recombinant factor VIIa by a thrombin-dependent mechanism Br J Haematol 2003 122 651
14. Hirschl MM Matzner MP Huber WO et al. Effect of desmopressin substitution during organ procurement on early renal allograft function Nephrol Dial Transplant 1996 11 173
15. Stepinska J Banaszewski M Konopka A Szajewski T Activated recombinant factor VII (rFVIIa) in bleeding management after therapy with IIb/IIIa-inhibitor tirofiban Thromb Haemost 2002 87 355
16. Ng HJ Koh LP Lee LH Successful control of postsurgical bleeding by recombinant factor VIIa in a renal failure patient given low molecular weight heparin and aspirin Ann Hematol 2003 82 257